3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Leukemia, Myeloid, Acute
10
Myelodysplastic Syndromes
8
Lymphoma, Non-Hodgkin
5
Leukemia, Biphenotypic, Acute
5
Leukemia
5
Hodgkin Disease
5
Burkitt Lymphoma
5
Anemia, Refractory, with Excess of Blasts
5
Myeloproliferative Disorders
4
Leukemia, Myelomonocytic, Chronic
4
Myelodysplastic-Myeloproliferative Diseases
3
Multiple Myeloma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphoma
3
Leukemia, Myeloid, Accelerated Phase
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Blast Crisis
3
Primary Myelofibrosis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Large-Cell, Anaplastic
2
Leukemia, Prolymphocytic
2
Leukemia, Myeloid, Chronic-Phase
2
Hematologic Neoplasms
2
Graft vs Host Disease
2
Congenital Abnormalities
2
Interventions
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Whole-Body Irradiation
×
30 days
×
Clear all
No trials found.